Technology
Transfer Tactics will be offering a webinar entitled "Analyzing and Adapting to the Supreme Court's
Myriad Ruling" on August 8, 2013 from 1:00 – 2:00 pm
(Eastern).  Patent Docs author Dr. Kevin Noonan of McDonnell Boehnen Hulbert
& Berghoff LLP will help clarify and assess the effects of the Myriad decision for IP and research
commercialization professionals, and provide guidance on how to adapt and
preserve or even enhance the value of gene-based technologies.  The webinar will cover the following topics:

•
Clearing the cobwebs: What's eligible, what's not, and what's in no-man's land
•
Impact on patented technologies — what now?
•
How to guide researchers with an eye on subject matter eligibility
•
Making adjustments to claim drafting strategy
•
Dealing with existing licenses, and impact on future licensing strategy
•
How the Myriad decision will force
changes at the USPTO
•
Assessing the potential impact on stem cell and other gene-based research
•
Unanswered questions still to be decided by interpreting courts, and where to
place your bets

The
registration fee for the webinar is $197. 
Those interested in registering for the webinar, can do so here.